NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

D型肝炎:流行病學的預測(2027年)

Hepatitis D - Epidemiology Forecast to 2028

出版商 DelveInsight Business Research LLP 商品編碼 534883
出版日期 按訂單生產 內容資訊 英文 50 Pages
商品交期: 2-10個工作天內
價格
D型肝炎:流行病學的預測(2027年) Hepatitis D - Epidemiology Forecast to 2028
出版日期: 按訂單生產內容資訊: 英文 50 Pages
簡介

主要8個國家D型肝炎的整體患病數,2016年推定為1,054萬6,938人。

本報告提供D型肝炎的相關調查,總括性彙整疾病概要,患者背景,主要8個國家(美國,英國,德國,法國,義大利,西班牙,日本,中國)的患病數趨勢,今後10年流行病學的預測,成長要素及市場障礙,今後市場機會等資訊。

目錄

第1章 重要的洞察

第2章 病的背景和概要:D型肝炎

  • 簡介
  • 分類
  • 帶來疾病的進展的影響的要素
  • 病因
  • 症狀
  • 發病機制
  • 病理生理學
  • 診斷
  • 預防

第3章 流行病學和患者人口

  • 主要的觀察
  • 主要8個國家的D型肝炎的患病數

第4章 D型肝炎的流行病學:各國

  • 美國
    • D型肝炎的患病數
    • D型肝炎的患病數:重症度別
    • D型肝炎的患病數:性別
    • D型肝炎的患病數:各年齡
    • D型肝炎的罹患數
  • 歐盟5國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
  • 日本
  • 中國

第5章 附錄

第6章 調查手法

第7章 DelveInsight的服務內容

第8章 免責聲明

第9章 關於DelveInsight

目錄
Product Code: DIEI0107

DelveInsight's 'Hepatitis D - Epidemiology Forecast to 2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Hepatitis D in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China.

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
  • China

Study Period: 2016-2028

Hepatitis D Epidemiology

The Hepatitis D epidemiology division provide the insights about historical and current patient pool and forecasted trend for each of the 8 major countries. The epidemiology data for Hepatitis D are studied through all possible division to give a better understanding about the Disease scenario in 8MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Hepatitis D Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [total prevalent cases, prevalence by Severity (Fulminant, Acute & Chronic), Gender Specific prevalence, Age Specific prevalence and diagnosed cases] of Hepatitis D in the 8MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom), Japan and China from 2016-2028.

The DelveInsight report also provides the epidemiology trends observed in the 8MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, total prevalent population of Hepatitis D in 8 major markets was estimated to be 10,546,938 in 2016.

Report Scope

  • The report covers detailed overview of Hepatitis D explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Hepatitis D in 8 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan and China.
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 8MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D

Key strengths

  • 10 Year Forecast of Hepatitis D epidemiology
  • 8MM Coverage
  • Diagnosed Prevalent cases of Hepatitis D
  • Prevalent Cases according to segmentation: by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D in 8MM

Key assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

Table of Contents

1. Key Insights

2. Disease Background and Overview: Hepatitis D

  • 2.1. Introduction
  • 2.2. Classification
  • 2.3. Factors influencing Hepatitis D Progression
  • 2.4. Disease Causes
  • 2.5. HDV-Symptoms
  • 2.6. Pathogenesis
  • 2.7. Pathophysiology
  • 2.8. HDV Diagnosis
  • 2.9. Prevention

3. Epidemiology and Patient Population

  • 3.1. Key Findings
  • 3.2. 8MM Prevalent Population of Hepatitis D

4. Country Wise-Epidemiology of Hepatitis D

  • 4.1. United States
    • 4.1.1. Prevalent cases of Hepatitis D in the United States
    • 4.1.2. Prevalent Population of Hepatitis D by severity
    • 4.1.3. Gender Specific Hepatitis D Prevalence
    • 4.1.4. Age Specific Hepatitis D Prevalence
    • 4.1.5. Diagnosed cases of Chronic Hepatitis D
  • 4.2. EU5
    • 4.2.1. Prevalent Population of Hepatitis D in EU5
  • 4.3. France
    • 4.3.1. Prevalent Population of Hepatitis D
    • 4.3.2. Prevalent Population of Hepatitis D by severity
    • 4.3.3. Gender Specific Hepatitis D Prevalence
    • 4.3.4. Age Specific Hepatitis D Prevalence
    • 4.3.5. Diagnosed cases of Chronic Hepatitis D
  • 4.4. Germany
    • 4.4.1. Prevalent Population of Hepatitis D
    • 4.4.2. Prevalent Population of Hepatitis D by severity
    • 4.4.3. Gender Specific Hepatitis D Prevalence
    • 4.4.4. Age Specific Hepatitis D Prevalence
    • 4.4.5. Diagnosed cases of Chronic Hepatitis D
  • 4.5. Italy
    • 4.5.1. Prevalent Population of Hepatitis D
    • 4.5.2. Prevalent Population of Hepatitis D by severity
    • 4.5.3. Gender Specific Hepatitis D Prevalence
    • 4.5.4. Age Specific Hepatitis D Prevalence
    • 4.5.5. Diagnosed cases of Chronic Hepatitis D
  • 4.6. Spain
    • 4.6.1. Prevalent Population of Hepatitis D
    • 4.6.2. Prevalent Population of Hepatitis D by severity
    • 4.6.3. Gender Specific Hepatitis D Prevalence
    • 4.6.4. Age Specific Hepatitis D Prevalence
    • 4.6.5. Diagnosed cases of Chronic Hepatitis D
  • 4.7. United Kingdom
    • 4.7.1. Prevalent Population of Hepatitis D
    • 4.7.2. Prevalent Population of Hepatitis D by severity
    • 4.7.3. Gender Specific Hepatitis D Prevalence
    • 4.7.4. Age Specific Hepatitis D Prevalence
    • 4.7.5. Diagnosed cases of Chronic Hepatitis D
  • 4.8. Japan
    • 4.8.1. Prevalent Population of Hepatitis D
    • 4.8.2. Prevalent Population of Hepatitis D by severity
    • 4.8.3. Gender Specific Hepatitis D Prevalence
    • 4.8.4. Age Specific Hepatitis D Prevalence
    • 4.8.5. Diagnosed cases of Chronic Hepatitis D
  • 4.9. China
    • 4.9.1. Prevalent Population of Hepatitis D
    • 4.9.2. Prevalent Population of Hepatitis D by severity
    • 4.9.3. Gender Specific Hepatitis D Prevalence
    • 4.9.4. Age Specific Hepatitis D Prevalence
    • 4.9.5. Diagnosed cases of Chronic Hepatitis D

5. Appendix

6. Report Methodology

  • 6.1. Sources Used

7. DelveInsight Capabilities

8. Disclaimer

9. About DelveInsight

List of Tables

  • Table 1: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 2: The United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 3: The United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 4: The United States, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Table 5: The United States, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 6: The United States, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 7: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 8: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 9: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 10: France, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 11: France, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 12: France, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 13: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 14: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 15: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Table 16: Germany, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 17: Germany, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 18: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 19: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 20: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Table 21: Italy, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 22: Italy, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 23: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 24: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 25: Spain, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 26: Spain, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 27: Spain, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 28: The United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 29: The United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 30: The United Kingdom, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 31: The United Kingdom, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Table 32: The United Kingdom, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 33: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 34: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 35: Japan, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 36: Japan, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 37: Japan, Diagnosed cases of Hepatitis D, 2016-2028
  • Table 38: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Table 39: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Table 40: China, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Table 41: China, Age Specific Hepatitis D Prevalence, 2016-2028
  • Table 42: China, Diagnosed cases of Hepatitis D, 2016-2028

List of Figures

  • Figure 1: Hepatitis Delta Virus Structure
  • Figure 2: Pathogenesis of Hepatitis D
  • Figure 3: Diagnostic markers in various hepatitis D disease patterns
  • Figure 4: 8MM, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 5: The United States, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 6: The United States, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 7: The United States, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 8: The United States, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 9: The United States, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 10: EU5, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 11: France, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 12: France, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 13: France, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 14: France, Age-specific Hepatitis D Prevalence, 2016-2028
  • Figure 15: France, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 16: Germany, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 17: Germany, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 18: Germany, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 19: Germany, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 20: Germany, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 21: Italy, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 22: Italy, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 23: Italy, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 24: Italy, Age-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 25: Italy, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 26: Spain, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 27: Spain, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 28: Spain, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 29: Spain, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 30: Spain, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 31: The United Kingdom, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 32: The United Kingdom, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 33: The United Kingdom, Gender-Specific Hepatitis D Prevalence, 2016-2028
  • Figure 34: The United Kingdom, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 35: The United Kingdom, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 36: Japan, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 37: Japan, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 38: Japan, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 39: Japan, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 40: Japan, Diagnosed cases of Hepatitis D, 2016-2028
  • Figure 41: China, Historical & Forecasted Hepatitis D Prevalence, 2016-2028
  • Figure 42: China, Historical & Forecasted Prevalence of Hepatitis D by severity, 2016-2028
  • Figure 43: China, Gender Specific Hepatitis D Prevalence, 2016-2028
  • Figure 44: China, Age Specific Hepatitis D Prevalence, 2016-2028
  • Figure 45: China, Diagnosed cases of Hepatitis D, 2016-2028